Medication use and symptomology in North American women with myalgic encephalomyelitis/chronic fatigue syndrome
Our study highlights the diverse and complex patterns in pharmacological treatment regimens for ME/CFS in women, while also underscoring the need for more tailored and evidence-based therapeutic strategies to address the varied symptom profiles.
Authors
- Jane Shearer (ORCID: https://orcid.org/0000-0002-1224-979X)
- Amy Moss (ORCID: https://orcid.org/0009-0000-9072-7446)
- Angela Pochakom (ORCID: https://orcid.org/0000-0002-2480-069X)
- Julia M. Martin (ORCID: https://orcid.org/0000-0001-9260-5784)
- Jill A. Parnell (ORCID: https://orcid.org/0000-0002-2936-0558)
- Sophie Lalonde-Bester (ORCID: https://orcid.org/0009-0002-0612-5560)
- Robyn F. Madden (ORCID: https://orcid.org/0000-0003-3097-9910)
- Eleanor Stein
- Gillian MacNevin
Institutions
- University of Alberta (CA)
- University of Calgary (CA)
- Mount Royal University (CA)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3389/fmed.2025.1543158
- Citations
- 1
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47